Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124003713 | 12400371 | 3 | F | 20160331 | 20160628 | 20160525 | 20160705 | EXP | GB-AMGEN-GBRSP2016048475 | AMGEN | 43.00 | YR | A | F | Y | 0.00000 | 20160705 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124003713 | 12400371 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 24 HOURS AFTER CHEMOTHERAPY | U | 125031 | 6 | MG | UNKNOWN FORMULATION | ||||||
| 124003713 | 12400371 | 2 | C | EMEND | APREPITANT | 1 | 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY)) | 0 | 80 | MG | QD | ||||||||
| 124003713 | 12400371 | 3 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | 0 | |||||||||||
| 124003713 | 12400371 | 4 | C | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | UNK | 0 | |||||||||||
| 124003713 | 12400371 | 5 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 | |||||||||||
| 124003713 | 12400371 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 2 MG, ONCE DAY, 3 DAYS | 0 | 2 | MG | QD | ||||||||
| 124003713 | 12400371 | 7 | C | DOCETAXEL. | DOCETAXEL | 1 | UNK, 3 CYCLES | 0 | |||||||||||
| 124003713 | 12400371 | 8 | C | FLUOROURACIL. | FLUOROURACIL | 1 | UNK UNK, EVERY THREE WEEKS (3 CYCLES) | 0 | Q3W | ||||||||||
| 124003713 | 12400371 | 9 | C | EPIRUBICIN | EPIRUBICIN | 1 | UNK UNK, EVERY THREE WEEKS (3 CYCLES) | 0 | Q3W | ||||||||||
| 124003713 | 12400371 | 10 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK UNK, EVERY THREE WEEKS (3 CYCLES) | 0 | Q3W |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124003713 | 12400371 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124003713 | 12400371 | OT |
| 124003713 | 12400371 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124003713 | 12400371 | Arthralgia | |
| 124003713 | 12400371 | Constipation | |
| 124003713 | 12400371 | Decreased appetite | |
| 124003713 | 12400371 | Deep vein thrombosis | |
| 124003713 | 12400371 | Fatigue | |
| 124003713 | 12400371 | Fear of disease | |
| 124003713 | 12400371 | Oral pain | |
| 124003713 | 12400371 | Pain | |
| 124003713 | 12400371 | Pain in extremity | |
| 124003713 | 12400371 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |